Posted by Michael Wonder on 18 Nov 2015
Regulatory submission for Sandoz' proposed biosimilar pegfilgrastim accepted by the FDA
18 November 2015 - Sandoz is seeking approval for the same indication as the reference product.
For more details, go to: https://www.novartis.com/news/media-releases/regulatory-submission-sandoz-proposed-biosimilar-pegfilgrastim-accepted-fda
